Johnson & Johnson revenue growth has been varied year-over-year.

What is JNJ's revenue growth rate?

Historical revenue data is available for Johnson & Johnson to analyze growth trends.

How fast is JNJ earnings growing?

Earnings growth data is available for Johnson & Johnson analysis.

What is JNJ's profit margin?

Profit margin data is available for Johnson & Johnson.

JNJ Revenue & Earnings Growth Analysis 2026 - Is Johnson & Johnson Growing?

Growth Summary

Johnson & Johnson (JNJ) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.

Over the past 4 years, Johnson & Johnson has achieved a revenue compound annual growth rate (CAGR) of 2.6%, while earnings have grown at -6.6% CAGR.

Latest Revenue

$94.19B

Net Income

$26.80B

5-Year Revenue CAGR

2.6%

4 years of data

Net Margin

N/A

Latest period

Revenue Growth Over Time

Historical revenue and profitability trends for Johnson & Johnson

The chart above illustrates Johnson & Johnson's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.

Year-over-Year Growth Rates

Annual percentage change in revenue and earnings

Growth rates provide insight into the momentum of Johnson & Johnson's business.

Profit Margin Trends

How efficiently Johnson & Johnson converts revenue into profit

Understanding Profit Margins

Profit margins reveal how much of each dollar of revenue Johnson & Johnson retains at different stages:

Gross Margin (N/A%): What remains after direct production costs
Operating Margin (N/A%): Profit from core operations before interest and taxes
Net Margin (N/A%): Final profit after all expenses

Future Growth Outlook

Analyst estimates and forward-looking indicators

EPS Estimate 2026

$11.53

Current: $11.13

EPS Estimate 2027

$12.54

8.8% expected growth

Price Target

$232.50

Analyst consensus

What Analysts Are Saying

Wall Street analysts project Johnson & Johnson to continue growing earnings in the coming year. The consensus analyst rating is 3.75 based on 24 analysts.

Growth Analysis Conclusion

Based on our comprehensive analysis, Johnson & Johnson (JNJ) demonstrates declining growth characteristics.

Key Takeaways:

Revenue Growth:, 2.6% CAGR over 4 years
Profitability: demonstrates the company is profitable
Efficiency:

Investment Considerations

This growth analysis provides a comprehensive view of Johnson & Johnson's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.